#USA #Plano #Bimini Health Tech #Puregraft #Dermapose

Bimini Health Tech Achieves EU MDR Certification

Bimini Health Tech, a prominent player in the global women’s health technology arena, has recently achieved certification under the EU Medical Device Regulation (MDR). This certification is a pivotal development for the company as it continues to expand its presence in international markets and aims to offer innovative solutions to healthcare providers and patients alike.

CEO Brad Conlan highlighted the significance of this certification, stating, "We are very pleased to achieve EU MDR certification for Bimini and also expand our product approvals for both our fat transfer product families, Puregraft and Dermapose. This milestone reflects the tireless dedication of our team and our continued investment in delivering high-quality, innovative technologies to patients and physicians around the world."

The accomplishment allows Bimini Health Tech to broaden its reach in Europe with its advanced fat transfer technologies, including the highly regarded Puregraft and Dermapose product lines. Recent reports from the International Society of Aesthetic Plastic Surgery (ISAPS) indicate a substantial increase in fat transfer procedures worldwide, with a 19.2% rise year-over-year, totaling over 940,000 procedures. With Bimini’s innovative products, the company is well-positioned to capture a notable share of this burgeoning market.

Exploring Bimini’s Product Portfolio

Puregraft Technology

The Puregraft® system is engineered for efficient large-volume fat filtration and purification, utilizing a closed-system workflow. Its patented dialyzing filtration technology adeptly separates healthy adipose tissue from blood, oil, and waste, ensuring a high concentration of viable fat cells. The Puregraft® product suite includes variants like Puregraft 50, 250, and 850, alongside the new Puregraft SYNC®, which has recently received FDA 510(k) clearance. Currently, Puregraft products are available in over 50 countries across the globe, allowing numerous patients to benefit from this state-of-the-art technology.

Dermapose Technology

On the other hand, the Dermapose® system is tailored for small-volume applications, facilitating a streamlined process where surgeons can harvest, purify, resize, and inject micro fat—all within a single closed system. This innovative approach not only enhances the efficiency of adipose processing but also promotes consistency and versatility in procedures. Following its EU MDR certification, Dermapose® is now accessible in various regions including the United States, EU, Japan, Brazil, Australia, Canada, and Saudi Arabia, making it a key player in the fat transfer technology landscape.

Bimini Health Tech’s Vision

Founded in 2013, Bimini Health Tech has established itself as a leader in women’s health market innovations. With a commitment to pioneering and commercializing medical technologies, the company offers a diverse array of products including the Puregraft Fat Filtration Systems and Essence Acellular Dermal Matrix. Bimini’s portfolio, which boasts over 100 patents, 20 device approvals, and numerous scientific publications, has been instrumental in more than 1.5 million procedures worldwide.

The success of Bimini Health Tech reflects a strong dedication to quality, innovation, and patient care, solidifying its position as a preferred choice among healthcare providers. As they move forward, the company remains focused on advancing women's health through cutting-edge technologies and is poised for further growth and success in coming years.

For more information on Bimini Health Tech and its range of products, visit www.biminihealthtech.com.